ATOMS: A Novel Continence Device for Stress Urinary Incontinence

What is it about?

The ATOMS device is a novel continence device for stress urinary incontinence (SUI) that can be adjusted post-surgery. This study evaluated its efficacy and safety in a New Zealand cohort of 140 patients, with a median follow-up of 11 months. The device improved pad usage in 82.9% of patients, with 76.4% reporting themselves dry. Complications occurred in 14.3% of patients. The ATOMS device appears to be a safe and effective option for SUI treatment, particularly in difficult patient cohorts.

Featured Image

Photo by chelsea fern on Unsplash

Photo by chelsea fern on Unsplash

Why is it important?

The research is important as it evaluates the clinical experience with a novel continence device, the adjustable transobturator male system (ATOMS), in the management of stress urinary incontinence (SUI). The study provides valuable insights into the efficacy and safety outcomes of the ATOMS device, which can potentially improve treatment options for patients with SUI. Key Takeaways: 1. The ATOMS device improves pad usage in 82.9% of patients and achieves dry rates of 76.4%. 2. The severity of preoperative SUI does not significantly impact the outcomes, suggesting a role for the ATOMS device in all patients. 3. The ATOMS device has a lower risk of urethral atrophy and erosion compared to other treatments like the AUS. 4. Patients with a history of previous radiation therapy had lower rates of improvement in pad usage and lower dry rates. 5. The ATOMS device offers the advantage of minimally invasive adjustment to respond to patient needs.